In addition, Fantone et al. [4] have indicated that SLC7A11 (also known as xCT) expression is significantly upregulated in ovarian cancers, resulting in the inhibition of ferroptosis, enhancing cancer cell proliferation, invasion, and chemoresistance. Here, SLC7A11 is linked to ovarian cancer.